Neuroendokrin daganatok: vizsgálatok itt: Olaszország
25 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleBelzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Where
- Bologna, Brescia, Milan, Naples, Siena, Verona
- Életkor
- 12 év and over
- People
- 355 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00 - 3. fázisTaking peopleDAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
- Where
- Bari, Florence, Milan, Naples, Palermo, Rome, Verona
- Életkor
- 18 év and over
- People
- 390 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07544654 · EU 2025-523869-22-00 - 2/3. fázisTaking peopleZanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Where
- Aviano, Bologna, Meldola, Milan, Naples, Orbassano to, Palermo, Roma
- Életkor
- 18 év and over
- People
- 440 worldwide
- Run by
- Exelixis
See details and how to joinNCT06943755 · EU 2025-521043-20-00 - No phaseTaking peopleMulticenter Study for External Validation of the TB-NET Score
- Where
- Milan
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
See details and how to joinNCT07903532 - 1. fázisTaking peoplePhase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
- Where
- Milan, Naples
- Életkor
- 18 év to 100 év
- People
- 116 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07006727 · EU 2024-519111-34-00 - 3. fázisTaking peopleStudy to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
- Where
- Ferrara, Genoa, Milan, Negrar, Pisa, Rome, Rozzano
- Életkor
- 12 év to 100 év
- People
- 240 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06784752 · EU 2024-518325-15-00 - No phaseTaking peopleIconographic Registry of Pancreatobiliary Endoscopy Procedures
- Where
- Milan
- Életkor
- 18 év and over
- People
- 12 000
- Run by
- IRCCS San Raffaele
See details and how to joinNCT06344507 - 3. fázisTaking peopleStudy Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide versus Durvalumab, Carboplatin, and Etoposide in First-Line ES-SCLC (DeLLphi-312)
- Where
- Bari, Bergamo, Meldola, Milan, Rome, Verona
- Életkor
- 18 év and over
- People
- 156 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-520050-38-00 · EU 2024-520050-38-00 - 2. fázisTaking peopleDAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Where
- Ancona, Brescia, Candiolo, Milan, Parma, Rome
- Életkor
- 18 év and over
- People
- 204 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT05882058 · EU 2023-504247-13-00 - 3. fázisTaking peopleEfficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
- Where
- Bari, Meldola, Milan, Reggio Emilia, Roma, Verona
- Életkor
- 18 év and over
- People
- 170 worldwide
- Run by
- Grupo Espanol de Tumores Neuroendocrinos
See details and how to joinNCT05918302 · EU 2022-502154-13-00 - 2. fázisNot yet taking people in OlaszországReceptor radionuclide therapy with 177Lu-DOTATOC (177Lu- edotreotide or 177Lu-octreotide) in SSTR positive patients: a multicenter, prospective, phase II trial
- Where
- Cesena, Meldola
- Életkor
- 18 év and over
- People
- 178
- Run by
- Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l.
See details and how to join2024-519183-40-00 · EU 2024-519183-40-00 - No phaseTaking peopleCompArative Analysis Between, Thymic, pulmonaRy and Pancreatic Well Differentiated High Grade Neuroendocrine Tumors
- Where
- Milan
- People
- 34
- Run by
- European Institute of Oncology
See details and how to joinNCT07429851 - No phaseTaking peopleInfluence of Tumour and Patient's Related Factors on the Response to Medical Treatments in Well Differentiated GEP-NENs
- Where
- Milan
- Életkor
- 18 év and over
- People
- 450
- Run by
- IRCCS San Raffaele
See details and how to joinNCT06356467 - No phaseTaking peopleDevelopment of New Personalised 3D Preclinical Models of Pancreatic Neuroendocrine Tumours
- Where
- Milan
- Életkor
- 18 év and over
- People
- 70
- Run by
- IRCCS San Raffaele
See details and how to joinNCT06121622 - No phaseTaking peopleRediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN)
- Where
- Rome
- Életkor
- 18 év to 80 év
- People
- 60
- Run by
- University of Roma La Sapienza
See details and how to joinNCT04464122 - No phaseTaking peopleUse of 68Ga-DOTATOC PET/CT-enterography for Detection of the Primary Lesion in Neuroendocrine Tumors of the Small Bowel
- Where
- Milan
- Életkor
- 18 év and over
- People
- 18
- Run by
- European Institute of Oncology
See details and how to joinNCT06773624 - 2. fázisTaking peopleMetronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study
- Where
- Milan
- Életkor
- 18 év and over
- People
- 46
- Run by
- European Institute of Oncology
See details and how to joinNCT05554003 - 2. fázisTaking peopleA Phase II trial aiming to assess the safety and activity of the combination of cabozantinib plus lanreotide in gastroenteropancreatic (GEP) and thoracic neuroendocrine tumor (NET): The LOLA trial
- Where
- Bari, Bologna, Brescia, Milan, Naples, Orbassano, Rome, Rozzano, Verona, Viagrande
- Életkor
- 18 év and over
- People
- 69
- Run by
- Fondazione IRCCS Istituto Nazionale Dei Tumori
See details and how to join2024-516612-16-00 · EU 2024-516612-16-00 - 2. fázisTaking peopleA Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers.
- Where
- Meldola
- Életkor
- 18 év and over
- People
- 51
- Run by
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
See details and how to joinNCT04166006 · EU 2023-510251-31-00 - 2. fázisTaking people"Receptor Radionuclide Therapy With 177Lu-DOTATOC
- Where
- Cesena, Meldola
- Életkor
- 18 év and over
- People
- 100
- Run by
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
See details and how to joinNCT06045260 - 2. fázisTaking peopleA Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM)
- Where
- Naples
- Életkor
- 18 év and over
- People
- 35
- Run by
- National Cancer Institute, Naples
See details and how to joinNCT04893785 - 2. fázisTaking peopleDurvalumab With Carboplatin and Etoposide Chemotherapy in Pulmonary Large-cell Neuroendocrine Carcinoma (LCNEC)
- Where
- Aviano, Bari, Bologna, Florence, Lucca, Meldola, Monza, Naples, Orbassano, Padova, Parma, Roma, Rozzano, Sassari, Viagrande
- Életkor
- 18 év and over
- People
- 49
- Run by
- Gruppo Oncologico Italiano di Ricerca Clinica
See details and how to joinNCT06418087 - No phaseTaking peopleYOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs.
- Where
- Milan
- Életkor
- 18 év to 39 év
- People
- 90
- Run by
- European Institute of Oncology
See details and how to joinNCT06337760 - No phaseTaking peopleProtocol ITANET - Registry
- Where
- Ancona, Bari, Bologna, Bolzano, Brescia, Brindisi, Catania, Ferrara, Genova, Latina, Messina, Milan, Modena, Monza, Naples, Padova, Palermo, Peschiera del Garda, Pisa, Reggio Emilia, Rho, Roma, Rome, Rozzano, San Giovanni Rotondo, Sassari, Siena, Torino, Trento, Verona
- Életkor
- 18 év and over
- People
- 3600
- Run by
- Italian Association Neuroendocrine Tumors
See details and how to joinNCT04282083 - No phaseTaking people68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours
- Where
- Milan
- Életkor
- 18 év and over
- People
- 300
- Run by
- IRCCS San Raffaele
See details and how to joinNCT06155318